Genting Crop Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -19.89%
- Profit Growth 369.36%
- Ebitda -67.59%
- Net Worth 444.03%
- Total Assets 33.42%
About Genting Crop Sciences
Genting Crop Sciences Private Limited (GCSPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 February 2020 (Four years and 11 months 29 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pawan Bansal and Ekansh Bansal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01110DL2020PTC361470
-
Company No.
361470
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Feb 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Genting Crop Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Bansal
|
Director | 02-Aug-2024 | Current |
|
Ekansh Bansal
|
Director | 05-Feb-2020 | Current |
Financial Performance of Genting Crop Sciences.
Genting Crop Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.89% decrease. The company also saw a substantial improvement in profitability, with a 369.36% increase in profit. The company's net worth Soared by an impressive increase of 444.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genting Crop Sciences?
Unlock access to Genting Crop Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Lexi Impex Private LimitedPawan Bansal and Ekansh Bansal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genting Crop Sciences?
Unlock and access historical data on people associated with Genting Crop Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genting Crop Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genting Crop Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
